Skip to main content Accessibility help
×
Home
  • Print publication year: 2017
  • Online publication date: June 2017

Chapter 11 - Contraception

Related content

Powered by UNSILO
1.World Health Organization. WHO/CONRAD Technical Consultation on Nonoxynol-9. October, 2001. [http://whqlibdoc.who.int/hq/2003/WHO_RHR_03.08.pdf]
2.Radcliffe, K, Edwards, S. BASHH Statement on HIV Window Period. October, 2014. [https://www.bashh.org]
3.de Bastos, M, Stegeman, BH, Rosendaal, FR, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev 2014;19(5):194.
4.Faculty of Sexual and Reproductive Healthcare. Venous Thromboembolism (VTE) and Hormonal Contraception. November, 2014. [www.fsrh.org]
5.Faculty of Sexual and Reproductive Healthcare. UK Medical Eligibility Criteria for Contraceptive Use. May, 2016. [www.fsrh.org]
6.Janssen-Cilag Ltd. Evra Transdermal Patch. Summary of Product Characteristics. May, 2016. [https://www.medicines.org.org/emc/medicine]
7.Gaffield, ME, Culwell, KR, Ravi, A. Oral contraceptives and family history of breast cancer. Contraception 2009;80:372–80.
8.Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. Emergency Contraception. August, 2011. [www.fsrh.org/pdfs/CEUguidance/Contraception]
9.Gallos, ID, Shehmar, M, Thangaratinam, S, et al. Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and meta-analysis. Am J Obstet Gynecol 2010;203:547–10.
10.Arowojolu, AO, Gallo, MF, Lopez, LM, Grimes, DA, Garner, SE. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2007;(1):CD004425.
11.Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. Progestogen-only Pills. March, 2015. [www.fsrh.org/pdfs/CEU/ProgestogenOnlyPills.pdf]
12.Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. Progestogen-only Injectable Contraception. December, 2014. [www.Users/pc/Downloads/cec-ceu-guidance-injectables-dec-2014.pdf]
13.Society of Obstetricians and Gynaecologists of Canada. Best Practices to Minimize Risk of Infection with Intrauterine Device Insertion. March, 2014. [www.sogc.org/wp-content/uploads]
14.Faculty of Sexual and Reproductive Health Care Clinical Effectiveness Unit. Contraception for Women Aged Over 40 Years. July, 2010. [www.fsrh.org/pdfs/ContraceptionOver40July10.pdf]
15.Faculty of Sexual and Reproductive Health Clinical Effectiveness Unit. Antibiotic Prophylaxis for Intrauterine Contraceptive Use in Women at Risk of Bacterial Endocarditis. July, 2008. [www.fsrh.org/pdfs]
16.Bayer. Could Essure® Be Right for Me? 2014. [www.essure.com/what-is-essure]